Project Confirm: Accelerated Drug Approvals for CML-Response

Clin Cancer Res. 2024 Jan 5;30(1):237-238. doi: 10.1158/1078-0432.CCR-23-3234.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Drug Approval*
  • Humans
  • Imatinib Mesylate

Substances

  • Antineoplastic Agents
  • Imatinib Mesylate